Loading…
Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas
Biologically active peptides are initially synthesized in the form of protein precursors, and the peptides are liberated by post-translational processing from the precursors in a tissue-specific manner. Mammalian proglucagon, which is synthesized in the neuroendocrine L-cells of the intestine and th...
Saved in:
Published in: | The Journal of biological chemistry 1990-05, Vol.265 (14), p.8001-8008 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Biologically active peptides are initially synthesized in the form of protein precursors, and the peptides are liberated by
post-translational processing from the precursors in a tissue-specific manner. Mammalian proglucagon, which is synthesized
in the neuroendocrine L-cells of the intestine and the alpha-cells of the pancreas, contains within its structure the sequences
of glucagon and two glucagon-like peptides (GLP-I and GLP-II) flanked at their amino and carboxyl termini by dibasic residues.
Tissue-specific processing liberates different peptides in the intestine compared with the pancreas. One of these intestinal
peptides, glucagon-like peptide I(7-37) (GLP-I(7-37], is one of the most potent insulin secretagogues studied to date. It
contains within its carboxyl-terminal domain an arginine residue that, because of an adjacent glycine residue, may alternatively
be used during post-translational processing as a site for amidation. Using a chromatographic system and radioimmunoassays
that discriminate among the closely related GLP-I peptides, we find that the processing of proglucagon in the rat intestine
and to a lesser extent in the rat pancreas results in the formation of at least three GLP-I peptides, of 37, 31, and 30 residues.
The 30-residue peptide is in the form of an alpha-carboxyl-terminal arginine amide, a modification that is not usually found
in proteins. Remarkably, the relative potencies for the stimulation of insulin secretion from the perfused rat pancreas of
the nonamidated (GLP-I(7-37] and the amidated (GLP-I(7-36) amide) peptides are the same (Weir, G. C., Mojsov, S., Hendrik,
G. K., and Habener, J. F. (1989) Diabetes 38, 338-342; Suzuki, S., Kawai, K., Okashir, S., Mukal, H., and Yamashita, K. (1989)
Endocrinology 125, 3109-3114). |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1016/s0021-9258(19)39030-1 |